Sponsored

Partner Content

Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective

Partner Content

Virtual clinical trials: How digital tech has improved clinical trial accrual rates

Partner Content

Laboratory services poised for the digital revolution

News

GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine

Partner Content

Understanding the current and future state of complex health data protection laws

News

FDA releases new guidance on decentralised clinical trials

News

Study finds mRNA vaccine and immunotherapy combo reduces melanoma recurrence

News

Nanoscope’s gene therapy nabs Phase II win in retinitis pigmentosa

Partner Content

Optimising biopharma production through process intensification

Partner Content

How automating clinical trial payments can unlock end-to-end efficiencies

News

US FDA clears Estrella’s IND to start B-Cell lymphomas therapy trial

News

REGENXBIO reports data from trial of Mucopolysaccharidosis Type I therapy

Partner Content

The Important Role that Biopharmaceutics Plays in Accelerating Early-Phase Drug Development

Partner Content

Pursuing Excellence in Clinical Supply Management ‒ Topic 4: Business Intelligence

Partner Content

Meet the company on a mission to transform research and advance healthcare

Partner Content

Cerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

Partner Content

Using analytics and bioassays to de-risk your mRNA LNP drug development programme

Partner Content

Strategies for Streamlining Small Molecule Formulation Development When Bridging from Candidate Selection to First-in-Human Clinical Testing

Features

Mapping endpoints: building gene therapy trials for the future

Partner Content

Overcoming challenges with scalability in biopharma manufacturing

Partner Content

New technologies fuel advancements in digital health

News

New year, new trials: Analysis reveals clinical trial activity trends in 2023

Urtė Fultinavičiūtė

Partner Content

Low-code/no-code platforms and SaaS: the next evolution in clinical trial technology

Miranda McLaren

Partner Content

Synthesis-to-Clinic®: integrating isotopic labeling and human ADME to reduce time to clinic

Partner Content

Race is on to claim share of biomanufacturing market

Partner Content

Medical affairs in a digital-first world: Benefits and challenges

Miranda McLaren

Partner Content

Tech innovations that curb complexity, setting clinical trials up for success

Miranda McLaren

Features

Sustainable supply chains: clinical trials in a new era of limited resources

Partner Content

Pursuing Excellence in Clinical Supply Management ‒ Topic 3: Planning Excellence

Partner Content

How to integrate IHC biomarkers for more effective clinical development in immuno-oncology

Miranda McLaren

Partner Content

Five Trends in Contract Drug Manufacturing Organisations

Partner Content

How Berlinger’s climate-focused innovation is helping to reduce, remove and offset emissions from the pharmaceutical supply

Partner Content

Managing the complexities of international clinical trials

Partner Content

Flow cytometry: advantages in immunotherapy clinical trials

Miranda McLaren

Partner Content

A new era in diagnostics: The growing demand for POC testing

Partner Content

The Canadian life sciences hub that may not be on your FDI radar (but should be)

Partner Content

What factors are driving life sciences FDI in 2022?

Cities

What factors are driving life sciences FDI in 2022?